Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region community news Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region AETOSWire sarjatha 18 July، 2022 London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement...Read More